Henry Schein

Henry Schein agreed to acquire a majority interest in TriMed, a developer of orthopedic solutions for foot, ankle, hand, and wrist, and formed a strategic relationship with Extremity Medical.

Henry Schein announced an agreement to acquire Brazilian dental implant manufacturer S.I.N. Implant System from Southern Cross Group. The transaction is subject to regulatory approval and expected to close in H2 2023.

Henry Schein completed the acquisition of a majority ownership stake in Biotech Dental S.A.S., a French provider of dental implants, clear aligners, and digital dental software. The transaction was announced on December 16, 2022.

Henry Schein announced a definitive agreement to acquire a majority ownership stake in Biotech Dental, a French provider of clinical software and oral surgery and orthodontic products. The transaction is subject to regulatory approvals; deal value not disclosed.

Henry Schein Inc. acquired a majority ownership position in Stradis Medical LLC, a provider of medical device packaging and custom procedure kits. The transaction was announced on March 31, 2021.

Camlog Holding GmbH (Henry Schein) notified the German Federal Cartel Office of its planned acquisition of 70% of shares and control over medentis medical GmbH. The companies operate in dental implants and attachments.

Henry Schein partnered with Cerebral Assessment Systems to distribute Cognivue, a computerized assessment screening device for early dementia detection.

Henry Schein Inc. announced plans to acquire Merritt Veterinary Supplies Inc., a family-owned supplier of animal health products serving approximately 4,500 veterinary clinics in the eastern U.S. The transaction is expected to close in the third quarter of 2017.

Dentsply Sirona announced a new distribution agreement with Henry Schein Canada, effective September 1, 2017 through December 31, 2020, expanding market opportunity for its dental products.